“…Based on the current model, ZEB1 is activated by the transforming growth factor beta (TGFβ) through TGFβ-SMAD signaling pathway ( Sanchez-Tillo et al., 2012 ). Mutations of ZEB1 have been linked to stem cell inefficiency ( Wang et al., 2020 ), immune deficiency ( Dean et al., 2015 ), and corneal endothelial dystrophy ( Liu et al., 2008b ; Zhang et al., 2021 ). We and others find that ZEB1 promotes both cell proliferation by inhibiting cyclin-dependent kinase inhibitors (CDKI) ( Liu et al., 2008a ) and migration by enhancing EMT properties ( Chen et al., 2017 ; Xue et al., 2019 ), whereas the loss of ZEB1 function mutation leads to cell senescence ( Liu et al., 2008a ).…”